|
|
Receipts
|
2,350,735,000
|
1,895,710,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Payments
|
(2,220,253,000)
|
(1,783,913,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividends Received
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Interest Received
|
531,000
|
146,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Interest Paid
|
(26,568,000)
|
(15,094,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Taxes Paid
|
(35,335,000)
|
(27,028,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Other
|
4,737,000
|
5,039,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Operating Cash Flow
|
73,847,000
|
74,860,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
Capital Expend. Excl. Investments
|
(10,464,000)
|
(11,647,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Payments for Investment
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Payments for Subsidiaries
|
-
|
(89,162,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Proceeds from PP&E
|
116,000
|
67,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Proceeds from Investments
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Proceeds from Subsidiaries
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Loans Granted
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Loans Repaid
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Other Investments
|
-
|
(2,252,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Investment Cash Flow
|
(10,348,000)
|
(102,994,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating CF less Investment CF
|
63,499,000
|
(28,134,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
Proceeds from Issues
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Proceeds from Borrowings
|
-
|
70,000,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Repayment of Borrowings
|
(7,000,000)
|
(4,083,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividends Paid
|
(41,261,000)
|
(15,473,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Other Financing Activities
|
(16,780,000)
|
(13,056,000)
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Financing Cash Flow
|
(65,041,000)
|
37,388,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Total Net Cashflow
|
(1,542,000)
|
9,254,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
Cash and Cash Equiv. Period Open
|
52,177,000
|
42,923,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Exchange Rate Adjustments
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Other Cash Adjustments
|
-
|
-
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash and Cash Equiv. Period Close
|
50,635,000
|
52,177,000
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|